PMH49 PREDICTORS OF TIME TO OUTPATIENT FOLLOW-UP AND COSTS AFTER HOSPITALIZATION AMONG MEDICAID BENEFICIARIES UTILIZING ORAL VERSUS LONG-ACTING INJECTABLE ANTIPSYCHOTICS IN BIPOLAR DISORDER OR SCHIZOPHRENIA
Abstract
Authors
L.M. Tidmore B. Holderread M. Abbott T. Cothran H. Waters K.L. Pareja S.L. Keast G.H. Skrepnek